{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:23:26Z","timestamp":1790360606878,"version":"4.1.0"},"publisher-location":"Cham","reference-count":25,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030391409","type":"print"},{"value":"9783030391416","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/7854_2018_82","type":"book-chapter","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T13:49:52Z","timestamp":1550497792000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Brief History of Immunological Research into Psychosis and Pathways for Immune Influence of the Brain"],"prefix":"10.1007","author":[{"given":"Norbert","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"82_CR1","volume-title":"Psychoneuroimmunology","year":"1981","unstructured":"Ader R (ed) (1981) Psychoneuroimmunology. Academic Press, New York"},{"issue":"Suppl 1","key":"82_CR2","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1055\/s-2004-828428","volume":"31","author":"K Bechter","year":"2004","unstructured":"Bechter K (2004) The mild encephalitis-hypothesis \u2013 new findings and studies. Psychiatr Prax 31(Suppl 1):S41\u2013S43. https:\/\/doi.org\/10.1055\/s-2004-828428","journal-title":"Psychiatr Prax"},{"issue":"12","key":"82_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","volume":"168","author":"ME Benros","year":"2011","unstructured":"Benros ME, Nielsen PR, Nordentoft M et al (2011) Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168(12):1303\u20131310. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11030516","journal-title":"Am J Psychiatry"},{"issue":"4610","key":"82_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1126\/science.6867729","volume":"221","author":"H Besedovsky","year":"1983","unstructured":"Besedovsky H, del Rey A, Sorkin E et al (1983) The immune response evokes changes in brain noradrenergic neurons. Science 221(4610):564\u2013566","journal-title":"Science"},{"issue":"3","key":"82_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","volume":"1","author":"A Carlsson","year":"1988","unstructured":"Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1(3):179\u2013186","journal-title":"Neuropsychopharmacology"},{"issue":"26","key":"82_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/0024-3205(89)90345-7","volume":"44","author":"R Dantzer","year":"1989","unstructured":"Dantzer R, Kelley KW (1989) Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 44(26):1995\u20132008","journal-title":"Life Sci"},{"issue":"2","key":"82_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000213565","volume":"59","author":"YK Kim","year":"2009","unstructured":"Kim YK, Myint AM, Verkerk R et al (2009) Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology 59(2):123\u2013129. https:\/\/doi.org\/10.1159\/000213565","journal-title":"Neuropsychobiology"},{"key":"82_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1055\/s-0029-1207083","volume":"16","author":"E Kraepelin","year":"1890","unstructured":"Kraepelin E (1890) \u00dcber Psychosen nach Influenza. Dtsch Med Wochenschr 16:209\u2013212","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"82_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","volume":"71","author":"W Laan","year":"2010","unstructured":"Laan W, Grobbee DE, Selten JP et al (2010) Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71(5):520\u2013527. https:\/\/doi.org\/10.4088\/JCP.09m05117yel","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"82_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/schbul\/sbq086","volume":"38","author":"KR Linderholm","year":"2012","unstructured":"Linderholm KR, Skogh E, Olsson SK et al (2012) Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr Bull 38(3):426\u2013432. https:\/\/doi.org\/10.1093\/schbul\/sbq086","journal-title":"Schizophr Bull"},{"issue":"3","key":"82_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000119472","volume":"24","author":"M Maes","year":"1990","unstructured":"Maes M, Bosmans E, Suy E et al (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115\u2013120","journal-title":"Neuropsychobiology"},{"issue":"1","key":"82_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E et al (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22(1):45\u201353","journal-title":"Psychol Med"},{"issue":"2","key":"82_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00221-006-0419-5","volume":"173","author":"U Meyer","year":"2006","unstructured":"Meyer U, Schwendener S, Feldon J et al (2006) Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 173(2):243\u2013257. https:\/\/doi.org\/10.1007\/s00221-006-0419-5","journal-title":"Exp Brain Res"},{"issue":"3","key":"82_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0920-9964(94)00045-A","volume":"14","author":"N Muller","year":"1995","unstructured":"Muller N, Ackenheil M (1995) Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology. Schizophr Res 14(3):223\u2013228","journal-title":"Schizophr Res"},{"key":"82_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1749-6632.1987.tb35830.x","volume":"496","author":"N Muller","year":"1987","unstructured":"Muller N, Ackenheil M, Eckstein R et al (1987) Reduced suppressor cell function in psychiatric patients. Ann N Y Acad Sci 496:686\u2013690","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"82_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0165-1781(91)90072-W","volume":"37","author":"N Muller","year":"1991","unstructured":"Muller N, Ackenheil M, Hofschuster E et al (1991) Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res 37(2):147\u2013160","journal-title":"Psychiatry Res"},{"issue":"5","key":"82_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0278-5846(93)90055-W","volume":"17","author":"N Muller","year":"1993","unstructured":"Muller N, Hofschuster E, Ackenheil M et al (1993) Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuro-Psychopharmacol Biol Psychiatry 17(5):713\u2013730","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"82_CR18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1176\/ajp.156.4.634","volume":"156","author":"N Muller","year":"1999","unstructured":"Muller N, Riedel M, Hadjamu M et al (1999) Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiatry 156(4):634\u2013636","journal-title":"Am J Psychiatry"},{"issue":"2","key":"82_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00406-004-0548-4","volume":"255","author":"N Muller","year":"2005","unstructured":"Muller N, Riedel M, Schwarz MJ et al (2005) Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci 255(2):149\u2013151. https:\/\/doi.org\/10.1007\/s00406-004-0548-4","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1\u20133","key":"82_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","volume":"121","author":"N Muller","year":"2010","unstructured":"Muller N, Krause D, Dehning S et al (2010) Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res 121(1\u20133):118\u2013124. https:\/\/doi.org\/10.1016\/j.schres.2010.04.015","journal-title":"Schizophr Res"},{"issue":"6","key":"82_CR21","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","volume":"39","author":"M Nitta","year":"2013","unstructured":"Nitta M, Kishimoto T, Muller N et al (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39(6):1230\u20131241. https:\/\/doi.org\/10.1093\/schbul\/sbt070","journal-title":"Schizophr Bull"},{"issue":"3","key":"82_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archpsyc.1989.01810030097017","volume":"46","author":"MH Rapaport","year":"1989","unstructured":"Rapaport MH, McAllister CG, Pickar D et al (1989) Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry 46(3):291\u2013292","journal-title":"Arch Gen Psychiatry"},{"key":"82_CR23","unstructured":"Rosenblum AS, Zakon SJ (trans) (1943) Relation of febrile disease to the psychoses. Arch Derm Syphilol 48:52, Russian. Trudi vrach. Odessk. g. boln. 1876\u20131877;1872"},{"key":"82_CR24","first-page":"79","volume":"76","author":"J Wagner-Jauregg","year":"1926","unstructured":"Wagner-Jauregg J (1926) Fieberbehandlung bei psychosen. Wien Med Wochenschr 76:79\u201382","journal-title":"Wien Med Wochenschr"},{"key":"82_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.04.004","volume":"92","author":"W Zheng","year":"2017","unstructured":"Zheng W, Cai DB, Yang XH et al (2017) Adjunctive celecoxib for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials. J Psychiatr Res 92:139\u2013146. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.04.004","journal-title":"J Psychiatr Res"}],"container-title":["Current Topics in Behavioral Neurosciences","Neuroinflammation and Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2018_82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T01:25:07Z","timestamp":1662945907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2018_82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030391409","9783030391416"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/7854_2018_82","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"19 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}